A study performed by Katsuki et al.12showed that patients with T2D and obesity had lower TNF‐α levels after treatment, while the levels of TNF‐α were unchanged in patients without obesity. The gene discussed is TNF; the disease is obesity due to melanocortin 4 receptor deficiency.